| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 8.25e-05 | 11 | 162 | 3 | GO:0005388 | |
| GeneOntologyCellularComponent | acrosomal vesicle | ATP8B3 SPATA31A3 SPATA31A7 DCST1 SPATA31A6 SPATA31A5 SPATA31A1 SPACA3 | 2.28e-04 | 206 | 164 | 8 | GO:0001669 |
| GeneOntologyCellularComponent | presynaptic membrane | 3.50e-04 | 277 | 164 | 9 | GO:0042734 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 3.72e-04 | 78 | 164 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | cell surface | SELE CFH LRFN1 NTRK1 CLSTN2 DSCAML1 SLC6A3 TYRO3 ACE2 TGFBR3 LIFR MELTF IGF2R KCNA5 FCN2 TLN1 ASTN1 PLAUR GPC2 IL4R | 4.56e-04 | 1111 | 164 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | serine-type endopeptidase complex | 4.90e-04 | 20 | 164 | 3 | GO:1905370 | |
| GeneOntologyCellularComponent | serine-type peptidase complex | 6.54e-04 | 22 | 164 | 3 | GO:1905286 | |
| GeneOntologyCellularComponent | DNA repair complex | 7.48e-04 | 23 | 164 | 3 | GO:1990391 | |
| Domain | DUF4599 | 2.50e-06 | 12 | 161 | 4 | PF15371 | |
| Domain | DUF4599 | 2.50e-06 | 12 | 161 | 4 | IPR027970 | |
| Domain | ATPase_P-typ_cyto_domN | 2.26e-04 | 35 | 161 | 4 | IPR023299 | |
| Domain | ATPase_P-typ_P_site | 2.53e-04 | 36 | 161 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 2.53e-04 | 36 | 161 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 2.53e-04 | 36 | 161 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 2.81e-04 | 37 | 161 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 2.81e-04 | 37 | 161 | 4 | PF00122 | |
| Domain | ATP_Ca_trans_C | 4.38e-04 | 4 | 161 | 2 | IPR022141 | |
| Domain | IMS | 4.38e-04 | 4 | 161 | 2 | PF00817 | |
| Domain | IMS_C | 4.38e-04 | 4 | 161 | 2 | PF11799 | |
| Domain | UMUC | 4.38e-04 | 4 | 161 | 2 | PS50173 | |
| Domain | ATP_Ca_trans_C | 4.38e-04 | 4 | 161 | 2 | PF12424 | |
| Domain | Carboxyl_trans | 4.38e-04 | 4 | 161 | 2 | PF01039 | |
| Domain | COA_CT_CTER | 4.38e-04 | 4 | 161 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 4.38e-04 | 4 | 161 | 2 | PS50980 | |
| Domain | COA_CT_N | 4.38e-04 | 4 | 161 | 2 | IPR011762 | |
| Domain | COA_CT_C | 4.38e-04 | 4 | 161 | 2 | IPR011763 | |
| Domain | - | 4.38e-04 | 4 | 161 | 2 | 3.30.1490.100 | |
| Domain | P-type_ATPase_IIB | 4.38e-04 | 4 | 161 | 2 | IPR006408 | |
| Domain | DNA_pol_Y-fam_little_finger | 4.38e-04 | 4 | 161 | 2 | IPR017961 | |
| Domain | Carboxyl_trans | 4.38e-04 | 4 | 161 | 2 | IPR000022 | |
| Domain | Cation_ATPase_N | 4.66e-04 | 18 | 161 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 4.66e-04 | 18 | 161 | 3 | SM00831 | |
| Domain | ATPase_P-typ_cation-transptr_N | 5.50e-04 | 19 | 161 | 3 | IPR004014 | |
| Domain | PHOSPHOPANTETHEINE | 7.26e-04 | 5 | 161 | 2 | PS00012 | |
| Domain | - | 1.08e-03 | 6 | 161 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 1.08e-03 | 6 | 161 | 2 | IPR016071 | |
| Domain | UmuC | 1.08e-03 | 6 | 161 | 2 | IPR001126 | |
| Domain | FN3 | 1.13e-03 | 185 | 161 | 7 | SM00060 | |
| Domain | FN3 | 1.72e-03 | 199 | 161 | 7 | PS50853 | |
| Domain | Epox_hydrolase-like | 2.00e-03 | 8 | 161 | 2 | IPR000639 | |
| Domain | FN3_dom | 2.27e-03 | 209 | 161 | 7 | IPR003961 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.54e-03 | 335 | 161 | 9 | IPR015943 | |
| Domain | - | 2.60e-03 | 32 | 161 | 3 | 3.40.1110.10 | |
| Domain | - | 2.60e-03 | 32 | 161 | 3 | 2.70.150.10 | |
| Domain | MAC_perforin | 3.18e-03 | 10 | 161 | 2 | IPR001862 | |
| Domain | Hydrolase_3 | 3.18e-03 | 10 | 161 | 2 | PF08282 | |
| Domain | Clathrin_mu | 3.18e-03 | 10 | 161 | 2 | IPR001392 | |
| Domain | Adap_comp_sub | 3.86e-03 | 11 | 161 | 2 | PF00928 | |
| Domain | WD40_repeat_dom | 4.30e-03 | 297 | 161 | 8 | IPR017986 | |
| Domain | MACPF | 4.61e-03 | 12 | 161 | 2 | IPR020864 | |
| Domain | MACPF | 4.61e-03 | 12 | 161 | 2 | SM00457 | |
| Domain | HAD-like_dom | 4.84e-03 | 79 | 161 | 4 | IPR023214 | |
| Domain | - | NRG1 LRFN1 COL12A1 NTRK1 DSCAML1 TYRO3 LIFR MALT1 RBPJ PLXNA4 ASTN1 IL4R SCN3B | 4.95e-03 | 663 | 161 | 13 | 2.60.40.10 |
| Domain | Kinesin_motor_CS | 5.27e-03 | 41 | 161 | 3 | IPR019821 | |
| Domain | MHD | 5.41e-03 | 13 | 161 | 2 | PS51072 | |
| Domain | MHD | 5.41e-03 | 13 | 161 | 2 | IPR028565 | |
| Domain | EGF-like_dom | 5.92e-03 | 249 | 161 | 7 | IPR000742 | |
| Domain | Kinesin-like_fam | 6.03e-03 | 43 | 161 | 3 | IPR027640 | |
| Domain | TUDOR | 6.28e-03 | 14 | 161 | 2 | PF00567 | |
| Domain | - | 6.43e-03 | 44 | 161 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 6.43e-03 | 44 | 161 | 3 | PF00225 | |
| Domain | KISc | 6.43e-03 | 44 | 161 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 6.43e-03 | 44 | 161 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 6.43e-03 | 44 | 161 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 6.43e-03 | 44 | 161 | 3 | PS50067 | |
| Domain | ATPase_P-typ_TM_dom | 8.19e-03 | 16 | 161 | 2 | IPR023298 | |
| Domain | - | 8.19e-03 | 16 | 161 | 2 | 1.20.1110.10 | |
| Domain | Ig-like_fold | NRG1 LRFN1 COL12A1 NTRK1 DSCAML1 TYRO3 LIFR MALT1 RBPJ PLXNA4 ASTN1 IL4R SCN3B | 8.22e-03 | 706 | 161 | 13 | IPR013783 |
| Domain | - | 8.38e-03 | 333 | 161 | 8 | 2.130.10.10 | |
| Pubmed | 1.35e-11 | 6 | 165 | 5 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.35e-11 | 6 | 165 | 5 | 25930072 | |
| Pubmed | 8.94e-08 | 24 | 165 | 5 | 32212159 | ||
| Pubmed | A genetic screen for behavioral mutations that perturb dopaminergic homeostasis in mice. | 1.05e-07 | 3 | 165 | 3 | 16436185 | |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 26187992 | ||
| Pubmed | ZNF157 SAMD4B BCORL1 MCCC2 FANCD2 JARID2 HNRNPUL2 FANCI SPEN ANAPC4 SMAD4 | 3.34e-06 | 396 | 165 | 11 | 26687479 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPHX1 PSAT1 KIF1A PNN DSG1 MCCC2 AP3B1 NDUFS1 FANCD2 JARID2 UBA1 AP2M1 IGF2R SF3B3 HNRNPUL2 FANCI RPTOR TLN1 RBPJ TDRD6 SPEN | 4.33e-06 | 1425 | 165 | 21 | 30948266 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MON2 RNGTT ZCCHC8 BCORL1 MCCC2 ZNF546 STRN SF3B3 RPTOR RBPJ POLK SPEN PCNT | 5.17e-06 | 588 | 165 | 13 | 38580884 |
| Pubmed | EPHX1 AHCYL1 USP24 ANKRD50 AP3B1 UBA1 IGF2R SF3B3 SEC24C MAP4K5 FANCI TLN1 XRN1 ASCC3 | 7.91e-06 | 708 | 165 | 14 | 39231216 | |
| Pubmed | 8.86e-06 | 282 | 165 | 9 | 23667531 | ||
| Pubmed | DDX60 JARID2 UBA1 AP2M1 IGF2R SEC24C HNRNPUL2 FANCI LOXL2 TLN1 PPME1 ATP2B4 ANAPC4 | 1.15e-05 | 634 | 165 | 13 | 34591612 | |
| Pubmed | KIF1A PNN ZCCHC8 USP24 NDUFS1 IGF2R SEC24C FANCI TLN1 XRN1 ASCC3 SPEN PCNT | 1.57e-05 | 653 | 165 | 13 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 LRFN1 PPRC1 PPP1R3B RTTN IGF2R FANCI RPTOR TLN1 BAMBI GPC2 MAPKBP1 SPEN PREX1 IL4R RIC1 PCNT | 2.20e-05 | 1105 | 165 | 17 | 35748872 |
| Pubmed | Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis. | 2.24e-05 | 2 | 165 | 2 | 28440309 | |
| Pubmed | DNA clamp function of the monoubiquitinated Fanconi anaemia ID complex. | 2.24e-05 | 2 | 165 | 2 | 32269332 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12594956 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21526496 | ||
| Pubmed | FANCI functions as a repair/apoptosis switch in response to DNA crosslinks. | 2.24e-05 | 2 | 165 | 2 | 34256011 | |
| Pubmed | FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. | 2.24e-05 | 2 | 165 | 2 | 19561358 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12665524 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 11668614 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28636932 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 30673607 | ||
| Pubmed | Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. | 2.24e-05 | 2 | 165 | 2 | 19465922 | |
| Pubmed | Expression and purification of human FANCI and FANCD2 using Escherichia coli cells. | 2.24e-05 | 2 | 165 | 2 | 25168188 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21372128 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 1313367 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 24278431 | ||
| Pubmed | FANCD2-FANCI surveys DNA and recognizes double- to single-stranded junctions. | 2.24e-05 | 2 | 165 | 2 | 39085614 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22252018 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 14668322 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25690014 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32725171 | ||
| Pubmed | Mechanism, specificity, and function of FANCD2-FANCI ubiquitination and deubiquitination. | 2.24e-05 | 2 | 165 | 2 | 34137174 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27773793 | ||
| Pubmed | FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2. | 2.24e-05 | 2 | 165 | 2 | 26430909 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 38377825 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 32167469 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 29059323 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 34637926 | ||
| Pubmed | FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. | 2.24e-05 | 2 | 165 | 2 | 17460694 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 27405460 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 19628463 | ||
| Pubmed | Structure of the FANCI-FANCD2 complex: insights into the Fanconi anemia DNA repair pathway. | 2.24e-05 | 2 | 165 | 2 | 21764741 | |
| Pubmed | Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. | 2.24e-05 | 2 | 165 | 2 | 16216224 | |
| Pubmed | NCOA3 PDE4D PNN ZCCHC8 SAMD4B USP24 UBA1 HNRNPUL2 FANCI RPTOR SPEN | 3.09e-05 | 503 | 165 | 11 | 16964243 | |
| Pubmed | 3.19e-05 | 186 | 165 | 7 | 20673868 | ||
| Pubmed | 3.19e-05 | 186 | 165 | 7 | 20452482 | ||
| Pubmed | 3.38e-05 | 418 | 165 | 10 | 34709266 | ||
| Pubmed | 6.01e-05 | 141 | 165 | 6 | 18636124 | ||
| Pubmed | Transcriptional regulation of the TGF-beta pseudoreceptor BAMBI by TGF-beta signaling. | 6.69e-05 | 3 | 165 | 2 | 15240101 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 26708753 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 30167850 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28695891 | ||
| Pubmed | Fanconi anemia FANCD2 and FANCI proteins regulate the nuclear dynamics of splicing factors. | 6.69e-05 | 3 | 165 | 2 | 29030393 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 23883285 | ||
| Pubmed | FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. | 6.69e-05 | 3 | 165 | 2 | 20671156 | |
| Pubmed | The E3 ubiquitin ligase RAD18 regulates ubiquitylation and chromatin loading of FANCD2 and FANCI. | 6.69e-05 | 3 | 165 | 2 | 21355096 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 23423485 | ||
| Pubmed | Multifaceted recognition of vertebrate Rev1 by translesion polymerases ζ and κ. | 6.69e-05 | 3 | 165 | 2 | 22700975 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 22206759 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 21040849 | ||
| Pubmed | Generation of a conditional knockout allele for mammalian Spen protein Mint/SHARP. | 6.69e-05 | 3 | 165 | 2 | 17457934 | |
| Pubmed | Mechanism of RAD51-dependent DNA interstrand cross-link repair. | 6.69e-05 | 3 | 165 | 2 | 21719678 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 32620897 | ||
| Pubmed | Defective FANCI binding by a fanconi anemia-related FANCD2 mutant. | 6.69e-05 | 3 | 165 | 2 | 25489943 | |
| Pubmed | A Fanci knockout mouse model reveals common and distinct functions for FANCI and FANCD2. | 6.69e-05 | 3 | 165 | 2 | 31219578 | |
| Pubmed | Regulation of the Fanconi anemia pathway by a CUE ubiquitin-binding domain in the FANCD2 protein. | 6.69e-05 | 3 | 165 | 2 | 22855611 | |
| Pubmed | Regulation of the Fanconi Anemia DNA Repair Pathway by Phosphorylation and Monoubiquitination. | 6.69e-05 | 3 | 165 | 2 | 34828369 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 26982350 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 36104590 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17242367 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 9566979 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 25080294 | ||
| Pubmed | SHARP is a novel component of the Notch/RBP-Jkappa signalling pathway. | 6.69e-05 | 3 | 165 | 2 | 12374742 | |
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 28684355 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 17689535 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 20211863 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 35305312 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 33051438 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 37930129 | ||
| Pubmed | 6.69e-05 | 3 | 165 | 2 | 29033321 | ||
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 7.29e-05 | 212 | 165 | 7 | 33462405 | |
| Pubmed | 8.12e-05 | 18 | 165 | 3 | 23726366 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | AHCYL1 IL18 PNN DSG1 MCCC2 NDUFS1 UBA1 AP2M1 SF3B3 SEC24C HNRNPUL2 MAP4K5 FANCI RPTOR TLN1 XRN1 ASCC3 NME7 | 8.21e-05 | 1353 | 165 | 18 | 29467282 |
| Pubmed | AHCYL1 PSAT1 USP24 CDK14 NDUFS1 FANCD2 UBA1 IGF2R SEC24C COG1 FANCI TLN1 GSTCD PPME1 | 8.25e-05 | 878 | 165 | 14 | 37223481 | |
| Pubmed | 9.11e-05 | 152 | 165 | 6 | 34299191 | ||
| Pubmed | Lung cancer susceptibility model based on age, family history and genetic variants. | 9.61e-05 | 19 | 165 | 3 | 19390575 | |
| Pubmed | 9.94e-05 | 300 | 165 | 8 | 19086053 | ||
| Pubmed | 1.06e-04 | 225 | 165 | 7 | 12168954 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | PSAT1 CETP CTSC FTCD ACE2 TGFBR3 MELTF UBA1 AP2M1 IGF2R FCN2 TLN1 GSTCD PKLR SPEN | 1.08e-04 | 1016 | 165 | 15 | 19056867 |
| Pubmed | Cell-specific expression of plasma membrane calcium ATPase isoforms in retinal neurons. | 1.33e-04 | 4 | 165 | 2 | 12209837 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 19037107 | ||
| Pubmed | Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. | 1.33e-04 | 4 | 165 | 2 | 15817713 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 12784250 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 23413890 | ||
| Pubmed | Quantitative analysis of alternative splicing options of human plasma membrane calcium pump genes. | 1.33e-04 | 4 | 165 | 2 | 8245032 | |
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 26336824 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 15938621 | ||
| Pubmed | 1.33e-04 | 4 | 165 | 2 | 27263974 | ||
| Cytoband | 6q16 | 1.27e-04 | 5 | 165 | 2 | 6q16 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 3.54e-04 | 8 | 165 | 2 | chr9q12 | |
| GeneFamily | Fibronectin type III domain containing | 3.98e-04 | 160 | 108 | 6 | 555 | |
| Coexpression | GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN | 4.00e-06 | 197 | 162 | 9 | M8133 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN | 4.53e-06 | 200 | 162 | 9 | M9777 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA3 NRG1 RNGTT USP24 AP3B1 JARID2 TGFBR3 MALT1 IGF2R MAP4K5 RBPJ PLAUR ASCC3 SPEN ATP2B4 SMAD4 PCNT CHST3 | 6.30e-06 | 856 | 162 | 18 | M4500 |
| Coexpression | YAGI_AML_WITH_INV_16_TRANSLOCATION | MON2 SELE ERG PNLIPRP1 PNN NTRK1 SLC6A11 MELTF KCNA5 SLC25A40 MAPKBP1 SPEN | 1.02e-05 | 411 | 162 | 12 | M1047 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | NRG1 RNGTT PPP1R3B CDK14 JARID2 CELF2 LOXL2 RBPJ XRN1 ASCC3 PCCB IL4R | 1.92e-05 | 438 | 162 | 12 | M227 |
| Coexpression | GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN | 3.62e-05 | 200 | 162 | 8 | M5073 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP | 5.28e-05 | 211 | 162 | 8 | M12225 | |
| Coexpression | GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 5.67e-05 | 157 | 162 | 7 | M6871 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATP13A4 COL12A1 FIGN DSCAML1 MELTF ASXL3 CNTNAP4 UNC79 UNC80 | 3.04e-08 | 184 | 165 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATP13A4 COL12A1 FIGN DSCAML1 MELTF ASXL3 CNTNAP4 UNC79 UNC80 | 3.04e-08 | 184 | 165 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ATP13A4 COL12A1 FIGN DSCAML1 MELTF ASXL3 CNTNAP4 UNC79 UNC80 | 3.04e-08 | 184 | 165 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_Hsd17b2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.74e-07 | 81 | 165 | 6 | 20796e59cdeb398e7772f4356578d74a33405f71 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.47e-07 | 197 | 165 | 8 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.71e-07 | 136 | 165 | 7 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.04e-06 | 167 | 165 | 7 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.96e-06 | 185 | 165 | 7 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.17e-06 | 186 | 165 | 7 | 84ba666237c18189d7e7556bd92dd953af733c00 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.86e-06 | 189 | 165 | 7 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.34e-06 | 191 | 165 | 7 | fd8331c7abdd999f55ba43d307945c6abfccbf84 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.86e-06 | 193 | 165 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-06 | 195 | 165 | 7 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.98e-06 | 197 | 165 | 7 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial-Proteoglycan-expressing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 165 | 7 | 94ef227b2162ba77af33b8cc8aaa4a7e3bdf79a7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Neuroepithelial|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.91e-06 | 200 | 165 | 7 | 429028c3112d279b26abf3296e01b1884b4b7fcb | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.98e-05 | 149 | 165 | 6 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.66e-05 | 157 | 165 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 160 | 165 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.39e-05 | 164 | 165 | 6 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 167 | 165 | 6 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.01e-05 | 169 | 165 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 4.15e-05 | 170 | 165 | 6 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | Globus_pallidus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Gfap_(Gfap)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 105 | 165 | 5 | c41264e8b7d306d5d3ffa5b29eb36c7131d1cedf | |
| ToppCell | Globus_pallidus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Gfap_(Gfap)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 105 | 165 | 5 | ed570cfdd452767dfb4dcae72282fe0fb25a4029 | |
| ToppCell | Globus_pallidus-Macroglia-ASTROCYTE-Gja1-Astrocyte.Gja1.Gfap_(Gfap)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 4.48e-05 | 105 | 165 | 5 | ed3a431195c42c96c7d9c420e4b9fb00f415012d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 4.72e-05 | 174 | 165 | 6 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.87e-05 | 175 | 165 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 4.87e-05 | 175 | 165 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 4.87e-05 | 175 | 165 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.19e-05 | 177 | 165 | 6 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.19e-05 | 177 | 165 | 6 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.19e-05 | 177 | 165 | 6 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 180 | 165 | 6 | b514c55e52b46e8a1a2f09ed2c59a7683367a505 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.70e-05 | 180 | 165 | 6 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 6.24e-05 | 183 | 165 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 183 | 165 | 6 | 0e8fb371d8eac777451c76f41d53577f5dfb740d | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.24e-05 | 183 | 165 | 6 | cbc3b00faa7e4e0dbbbc8ee105467c65241c7470 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 187 | 165 | 6 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | COVID-19-kidney-Stressed_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 7.04e-05 | 187 | 165 | 6 | acd305475f3609800af0d7bc68d83ef41228080b | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.04e-05 | 187 | 165 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.04e-05 | 187 | 165 | 6 | 85645de9069bd9a8a02d53b0d3d73bf9c2b57189 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.04e-05 | 187 | 165 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 188 | 165 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 188 | 165 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 188 | 165 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-05 | 188 | 165 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 7.46e-05 | 189 | 165 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.46e-05 | 189 | 165 | 6 | fb2253b8463d08b3d28e952a31a23dea2c2d986b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 189 | 165 | 6 | 8e6b6025f5554672e26a5d19fe365acb4333789c | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 7.46e-05 | 189 | 165 | 6 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.68e-05 | 190 | 165 | 6 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.68e-05 | 190 | 165 | 6 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.37e-05 | 193 | 165 | 6 | 516ea2c12bdc7a5dc676159d627e36f6abe13ef0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.62e-05 | 194 | 165 | 6 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.62e-05 | 194 | 165 | 6 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.86e-05 | 195 | 165 | 6 | 2514c1f23424b5fc664d326d31ffd22bafe74ef8 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 196 | 165 | 6 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-05 | 196 | 165 | 6 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.11e-05 | 196 | 165 | 6 | e4d04e1f82779e8afd4e32bbe38d1d3f6f64ab50 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.11e-05 | 196 | 165 | 6 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-05 | 196 | 165 | 6 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 196 | 165 | 6 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.11e-05 | 196 | 165 | 6 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 196 | 165 | 6 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-05 | 196 | 165 | 6 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.11e-05 | 196 | 165 | 6 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-05 | 197 | 165 | 6 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-05 | 197 | 165 | 6 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 9.64e-05 | 198 | 165 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.64e-05 | 198 | 165 | 6 | 09be07ebfc3e49c3858e9b74605b69cf4fc28b56 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.64e-05 | 198 | 165 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.64e-05 | 198 | 165 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.64e-05 | 198 | 165 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | E18.5-Mesenchymal|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.64e-05 | 198 | 165 | 6 | a16aa41eab2e297e56de43c22c355df0f79315da | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-05 | 199 | 165 | 6 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.91e-05 | 199 | 165 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-05 | 199 | 165 | 6 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-05 | 199 | 165 | 6 | 6200618e029063486719479c41eaf31798bd13cf | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.91e-05 | 199 | 165 | 6 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | E16.5-Mesenchymal|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-05 | 199 | 165 | 6 | ebd9ca151434f5ca27a82d4f1815a1ea500c1989 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-05 | 199 | 165 | 6 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.91e-05 | 199 | 165 | 6 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.02e-04 | 200 | 165 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.02e-04 | 200 | 165 | 6 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.02e-04 | 200 | 165 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.02e-04 | 200 | 165 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.11e-04 | 127 | 165 | 5 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| Disease | total cholesterol measurement, diastolic blood pressure, triglyceride measurement, systolic blood pressure, hematocrit, ventricular rate measurement, glucose measurement, body mass index, high density lipoprotein cholesterol measurement | 7.71e-06 | 51 | 157 | 5 | EFO_0004340, EFO_0004348, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928 | |
| Disease | triglycerides in IDL measurement | 1.46e-05 | 58 | 157 | 5 | EFO_0022149 | |
| Disease | phospholipids in VLDL measurement | 1.59e-05 | 59 | 157 | 5 | EFO_0022301 | |
| Disease | interstitial lung disease (is_implicated_in) | 1.73e-05 | 10 | 157 | 3 | DOID:3082 (is_implicated_in) | |
| Disease | respiratory syncytial virus infectious disease (is_implicated_in) | 1.73e-05 | 10 | 157 | 3 | DOID:1273 (is_implicated_in) | |
| Disease | total lipids in VLDL measurement | 1.73e-05 | 60 | 157 | 5 | EFO_0022314 | |
| Disease | free cholesterol in VLDL measurement | 1.87e-05 | 61 | 157 | 5 | EFO_0022276 | |
| Disease | cysteine-rich with EGF-like domain protein 1 measurement | 2.47e-05 | 32 | 157 | 4 | EFO_0021870 | |
| Disease | cholesterol in large VLDL measurement | 2.55e-05 | 65 | 157 | 5 | EFO_0021902 | |
| Disease | cholesterol in very large VLDL measurement | 2.55e-05 | 65 | 157 | 5 | EFO_0022230 | |
| Disease | cerebral malaria (is_implicated_in) | 2.81e-05 | 2 | 157 | 2 | DOID:14069 (is_implicated_in) | |
| Disease | total lipids in small VLDL | 2.96e-05 | 67 | 157 | 5 | EFO_0022148 | |
| Disease | triglycerides in very small VLDL measurement | 3.18e-05 | 68 | 157 | 5 | EFO_0022144 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.18e-05 | 68 | 157 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 3.42e-05 | 69 | 157 | 5 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | triglycerides in large LDL measurement | 8.10e-05 | 43 | 157 | 4 | EFO_0022319 | |
| Disease | leukemia inhibitory factor receptor measurement | 8.41e-05 | 3 | 157 | 2 | EFO_0010788 | |
| Disease | Malignant neoplasm of prostate | EPHX1 NCOA3 IL18 PDE4D ERG LIFR IGF2R CELF2 GSTCD PLAUR POLK SPEN | 1.20e-04 | 616 | 157 | 12 | C0376358 |
| Disease | Prostatic Neoplasms | EPHX1 NCOA3 IL18 PDE4D ERG LIFR IGF2R CELF2 GSTCD PLAUR POLK SPEN | 1.20e-04 | 616 | 157 | 12 | C0033578 |
| Disease | Hypertriglyceridemia | 1.35e-04 | 19 | 157 | 3 | EFO_0004211 | |
| Disease | phospholipids in medium LDL measurement | 1.36e-04 | 49 | 157 | 4 | EFO_0022183 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.47e-04 | 50 | 157 | 4 | EFO_0022334 | |
| Disease | Intellectual Disability | ZCCHC8 RNF113A RTTN SLC6A3 ACE2 LINS1 AP2M1 NRXN2 ASTN1 ASCC3 | 1.49e-04 | 447 | 157 | 10 | C3714756 |
| Disease | endoglin measurement | 1.68e-04 | 4 | 157 | 2 | EFO_0008118 | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 1.68e-04 | 4 | 157 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.75e-04 | 291 | 157 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.95e-04 | 222 | 157 | 7 | EFO_0008317, EFO_0020943 | |
| Disease | total lipids in medium VLDL | 1.98e-04 | 54 | 157 | 4 | EFO_0022153 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 2.23e-04 | 160 | 157 | 6 | DOID:5844 (biomarker_via_orthology) | |
| Disease | phospholipids:total lipids ratio | 2.23e-04 | 227 | 157 | 7 | EFO_0020946 | |
| Disease | triglycerides in LDL measurement | 2.28e-04 | 56 | 157 | 4 | EFO_0022320 | |
| Disease | cholesterol to total lipids in large LDL percentage | 2.28e-04 | 56 | 157 | 4 | EFO_0022235 | |
| Disease | low density lipoprotein particle size measurement | 2.62e-04 | 58 | 157 | 4 | EFO_0008593 | |
| Disease | triglycerides to total lipids in small VLDL percentage | 2.62e-04 | 58 | 157 | 4 | EFO_0022338 | |
| Disease | cholesterol to total lipids in IDL percentage | 2.98e-04 | 60 | 157 | 4 | EFO_0022233 | |
| Disease | triglycerides in small VLDL measurement | 3.18e-04 | 61 | 157 | 4 | EFO_0022145 | |
| Disease | free cholesterol in very large VLDL measurement | 3.18e-04 | 61 | 157 | 4 | EFO_0022274 | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 3.26e-04 | 111 | 157 | 5 | EFO_0004530, EFO_0008595 | |
| Disease | phospholipids in large VLDL measurement | 3.38e-04 | 62 | 157 | 4 | EFO_0022169 | |
| Disease | triglycerides in medium LDL measurement | 3.38e-04 | 62 | 157 | 4 | EFO_0022322 | |
| Disease | phospholipids in very large VLDL measurement | 3.38e-04 | 62 | 157 | 4 | EFO_0022299 | |
| Disease | lipoprotein A measurement | 3.39e-04 | 112 | 157 | 5 | EFO_0006925 | |
| Disease | Micronuclei, Chromosome-Defective | 3.51e-04 | 26 | 157 | 3 | C1449861 | |
| Disease | Micronuclei, Genotoxicant-Induced | 3.51e-04 | 26 | 157 | 3 | C1449862 | |
| Disease | free cholesterol to total lipids in medium LDL percentage | 3.60e-04 | 63 | 157 | 4 | EFO_0022283 | |
| Disease | Liver carcinoma | 4.05e-04 | 507 | 157 | 10 | C2239176 | |
| Disease | NTF2-related export protein 1 measurement | 4.16e-04 | 6 | 157 | 2 | EFO_0801847 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 4.16e-04 | 6 | 157 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | total lipids in large VLDL | 4.56e-04 | 67 | 157 | 4 | EFO_0022175 | |
| Disease | free cholesterol in large VLDL measurement | 4.82e-04 | 68 | 157 | 4 | EFO_0022265 | |
| Disease | complement factor H-related protein 2 measurement | 4.88e-04 | 29 | 157 | 3 | EFO_0600055 | |
| Disease | pulmonary hypertension (is_implicated_in) | 5.40e-04 | 30 | 157 | 3 | DOID:6432 (is_implicated_in) | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 5.80e-04 | 7 | 157 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | anosmin-1 measurement | 5.80e-04 | 7 | 157 | 2 | EFO_0802284 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 5.99e-04 | 72 | 157 | 4 | EFO_0008300 | |
| Disease | Amphetamine-Related Disorders | 6.99e-04 | 75 | 157 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 6.99e-04 | 75 | 157 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 6.99e-04 | 75 | 157 | 4 | C0236804 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 7.28e-04 | 200 | 157 | 6 | EFO_0004611, EFO_0020945 | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0801556 | |
| Disease | central serous retinopathy | 7.71e-04 | 8 | 157 | 2 | EFO_0009784 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0020829 | |
| Disease | neurexophilin-1 measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0008244 | |
| Disease | programmed cell death 1 ligand 2 measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0008268 | |
| Disease | opioid-binding protein/cell adhesion molecule measurement | 7.71e-04 | 8 | 157 | 2 | EFO_0020618 | |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 8.50e-04 | 137 | 157 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | free cholesterol in small HDL measurement | 8.54e-04 | 35 | 157 | 3 | EFO_0022270 | |
| Disease | Schizophrenia | NRG1 PSAT1 IL18 PDE4D NTRK1 NDUFS1 SLC6A3 JARID2 LIFR SLC6A11 CELF2 NRXN2 PCNT | 9.17e-04 | 883 | 157 | 13 | C0036341 |
| Disease | pulmonary tuberculosis (is_marker_for) | 9.28e-04 | 36 | 157 | 3 | DOID:2957 (is_marker_for) | |
| Disease | Idiopathic pulmonary hypertension | 9.88e-04 | 9 | 157 | 2 | C0152171 | |
| Disease | DCN1-like protein 5 measurement | 9.88e-04 | 9 | 157 | 2 | EFO_0801520 | |
| Disease | apolipoprotein A-V measurement | 9.88e-04 | 9 | 157 | 2 | EFO_0801387 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 9.88e-04 | 9 | 157 | 2 | EFO_0801766 | |
| Disease | Endomyocardial Fibrosis | 9.88e-04 | 9 | 157 | 2 | C0553980 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.01e-03 | 37 | 157 | 3 | EFO_0022252 | |
| Disease | triglyceride measurement, C-reactive protein measurement | 1.09e-03 | 38 | 157 | 3 | EFO_0004458, EFO_0004530 | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.12e-03 | 85 | 157 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | very low density lipoprotein cholesterol measurement, lipid measurement | 1.19e-03 | 220 | 157 | 6 | EFO_0004529, EFO_0008317 | |
| Disease | level of phosphatidylcholine | 1.23e-03 | 10 | 157 | 2 | OBA_2040179 | |
| Disease | WNT1-inducible-signaling pathway protein 1 measurement | 1.23e-03 | 10 | 157 | 2 | EFO_0008321 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoleoyl-GPC (P-16:0/16:1) measurement | 1.23e-03 | 10 | 157 | 2 | EFO_0800464 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.23e-03 | 10 | 157 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 1.27e-03 | 150 | 157 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 1.34e-03 | 225 | 157 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.35e-03 | 152 | 157 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipid measurement | 1.46e-03 | 229 | 157 | 6 | EFO_0004639, EFO_0008317 | |
| Disease | aortic valve stenosis (is_marker_for) | 1.50e-03 | 11 | 157 | 2 | DOID:1712 (is_marker_for) | |
| Disease | gastrin-releasing peptide measurement | 1.50e-03 | 11 | 157 | 2 | EFO_0022000 | |
| Disease | amino acid metabolic disorder (is_implicated_in) | 1.50e-03 | 11 | 157 | 2 | DOID:9252 (is_implicated_in) | |
| Disease | hemopexin measurement | 1.50e-03 | 11 | 157 | 2 | EFO_0008149 | |
| Disease | Situs Inversus | 1.50e-03 | 11 | 157 | 2 | C0037221 | |
| Disease | receptor-interacting serine/threonine-protein kinase 2 measurement | 1.50e-03 | 11 | 157 | 2 | EFO_0802997 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 1.56e-03 | 43 | 157 | 3 | EFO_0022254 | |
| Disease | cholesterol to total lipids in large VLDL percentage | 1.78e-03 | 45 | 157 | 3 | EFO_0022236 | |
| Disease | metachronous colorectal adenoma | 1.78e-03 | 45 | 157 | 3 | EFO_0803377 | |
| Disease | economic and social preference | 1.82e-03 | 97 | 157 | 4 | EFO_0004827 | |
| Disease | free cholesterol in very small VLDL measurement | 2.02e-03 | 47 | 157 | 3 | EFO_0022275 | |
| Disease | level of Phosphatidylcholine (16:0_18:3) in blood serum | 2.11e-03 | 13 | 157 | 2 | OBA_2045072 | |
| Disease | MAP kinase-activated protein kinase 3 measurement | 2.11e-03 | 13 | 157 | 2 | EFO_0008226 | |
| Disease | Graves ophthalmopathy (is_marker_for) | 2.11e-03 | 13 | 157 | 2 | DOID:0081120 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NKVNGFTCIVQEDMP | 461 | Q7L0X2 | |
| QTMEGCSSPIVVKFA | 196 | O95319 | |
| GFPSQAQVTVHCLKM | 331 | P11597 | |
| ADVIGKSMNQAICIP | 541 | Q9UJX5 | |
| LMTCQPGVTAQEKVN | 11 | P07357 | |
| AEGTPCISKEVMCQL | 161 | A4D0V7 | |
| NKVLMPCDAVLIEGS | 291 | Q4VNC1 | |
| GSTPIGKQIMKSCAV | 671 | Q3SY69 | |
| PARVTIKMECNPSQV | 61 | P11308 | |
| TQMSKQVDCSPAGVK | 146 | Q5H9F3 | |
| KPQIIAMGNVSFSCS | 351 | Q9C0A0 | |
| GQSETVVICANPKGM | 371 | Q6NUN0 | |
| KTPLMTACASGNIDV | 526 | Q9NU02 | |
| SQCKIMIPSAQQEIG | 1326 | Q9ULJ7 | |
| KMASFQGTVTCEAPN | 296 | O60423 | |
| ALPKAQTTVTCMENG | 421 | P08603 | |
| NCQGMDSVIKPLDTI | 51 | O94921 | |
| KMSIQGCVAQPSSFL | 366 | Q8N6Q3 | |
| PGKMESQKVISCLQA | 526 | Q9H4D0 | |
| APLGRSVEVTKMSCQ | 561 | A6H8M9 | |
| GACITQDSPLKAVQM | 896 | Q01814 | |
| GACITQDSPLKAVQM | 861 | P23634 | |
| GGMQVVSLAPTCLQK | 161 | Q6HA08 | |
| CAMPSQVPDKQLTTI | 1101 | O14525 | |
| KMEGSTGVIIVNPNC | 1151 | Q9C0F0 | |
| MLKTIQGTDTPCIAI | 1281 | Q9C0F0 | |
| QPCIFGDKMVSIQIT | 891 | O00203 | |
| MILNPEGDVNSAKVC | 531 | Q9NTZ6 | |
| IKSVLTVNPCMSNQE | 406 | Q4ADV7 | |
| ICNKISEMIQGLATP | 176 | Q9NVH2 | |
| APACGDVMKLQIQVD | 66 | Q9H1K1 | |
| FTGARCTENVPMKVQ | 216 | Q02297 | |
| MVGQVKQCEGITSPE | 231 | Q9Y570 | |
| SVVTNCALIGMSPQV | 566 | Q9NW15 | |
| LQVCQSSGGIPKNME | 1181 | Q9NVI1 | |
| SKVCSPVSGILFNNM | 406 | A6NGU5 | |
| MNCVPDVITASKAGV | 121 | Q5HY92 | |
| MPNASCGVPTLKVQV | 186 | P04629 | |
| VAPVCLKTNSQMSGS | 71 | Q8NG48 | |
| DGAKMVAAVACAQVP | 421 | Q9HCC0 | |
| TAMAVCNSISNPVTK | 541 | O60942 | |
| QKLMPGSTLVLQCVA | 236 | Q9UDY8 | |
| ALKVPVSEGCSQALM | 241 | Q8N158 | |
| TGVKVCPQESMKQIL | 76 | Q17R60 | |
| QNVAPTLTMLCAKTG | 41 | Q9P244 | |
| SIGPSIVCKSIQMNQ | 186 | Q8N3X6 | |
| MTENVVCTGAVNAVK | 1 | Q96DD0 | |
| VSLDPMKNVTCENGL | 281 | Q9Y4K0 | |
| MKNVTCENGLPAVVS | 286 | Q9Y4K0 | |
| TGTLALGVNMPCKSV | 1291 | Q8IY21 | |
| LGVNMPCKSVVFAQN | 1296 | Q8IY21 | |
| PTECQTGQLKRIVMS | 196 | Q8N1V2 | |
| GRMCPATQKLIEESQ | 246 | Q9H307 | |
| AGSNVVVMFGKQPCL | 981 | Q9HCM2 | |
| SMPGCKKNALSQIVD | 251 | P54315 | |
| PMCNQPSINKATITE | 256 | Q08499 | |
| NKIPSMQVGFIDAIC | 811 | O76074 | |
| LSAQMKAVSAECLGP | 1141 | O75037 | |
| KGARTAPLQCVSMAE | 1291 | O75037 | |
| AKVTQNLPMKEGCTE | 296 | Q1KMD3 | |
| SPVSNNFMGCLKDVV | 441 | Q9P2S2 | |
| FIGNAKTCMIANISP | 511 | Q5T7B8 | |
| VKCSSLAVPGKINMS | 491 | P16581 | |
| TPDSCIISMVVGQLK | 76 | P61970 | |
| NLAGKPVVCATQMLE | 361 | P30613 | |
| NCLSDAGVRKMTAPV | 211 | Q9Y546 | |
| TPLNTSGVQVICMKG | 326 | Q96CW1 | |
| TVTCKCDLEGIMPNV | 236 | Q9H0R1 | |
| KENSSEVVQPFLMGC | 61 | Q7Z3U7 | |
| VPAMIKLACGDTSLN | 181 | O95371 | |
| MAEQLSPGKAVDQVC | 1 | O15541 | |
| APLCKQEGVMSVLTV | 2011 | O95613 | |
| LTEGVKTSGMPEICQ | 656 | Q02413 | |
| SSCQVGELVIPNLMA | 356 | Q96CB9 | |
| IGEPQDFTCKTRQTM | 651 | Q5T6X5 | |
| ICKIMDQAITVGAPV | 141 | P05166 | |
| LRVVTVCNGNTMPLA | 461 | Q7RTM1 | |
| SLQGVDPETCMIVFK | 16 | Q05DH4 | |
| ASSGNMKVLQEPTCV | 21 | P24394 | |
| ICTNMAQLVPSHVKG | 231 | P07099 | |
| CPSKAGFSRNIMNII | 346 | P22460 | |
| SGLSMKAQAISPCVQ | 501 | Q8WTW3 | |
| GQVAKLDLECMVPVS | 206 | Q13145 | |
| MATKSCPECDQQVPV | 11 | Q6PH81 | |
| KTQPMKVQVECSRGV | 421 | Q99715 | |
| AVEVGPKSTMVCQHV | 596 | A8K855 | |
| IFPCKPTIQASEMSN | 441 | Q5T197 | |
| EKVVNPGEQFSLMCA | 416 | Q8TD84 | |
| LQAADTCPEVKMVGL | 26 | Q15485 | |
| DVNCSVMGPQEKKVV | 51 | P53634 | |
| SMLTDPGNVQKAVCH | 331 | Q9BYF1 | |
| RITMICLPQTKGATN | 61 | Q6UWE3 | |
| AGCKMPSAEQSRIAQ | 1441 | O60336 | |
| SQPRGMAVTISVKCE | 91 | Q14116 | |
| GSLSPMVITCQAVVN | 1146 | D6RIA3 | |
| IPCTSDMAKQAQVPL | 381 | P53992 | |
| DTVICAMKITQEPQG | 176 | Q8IXA5 | |
| VQVISMEPESCSPKN | 611 | Q8NEC7 | |
| SPQMKALACVSAEGV | 1076 | Q5VV67 | |
| PCVAMEIQQNNATKT | 306 | Q9Y5B8 | |
| MSQLVECVPNFSEGK | 1 | O95954 | |
| IVNAFCQETSPEMKG | 796 | Q9BXW9 | |
| DQQAMLKTPNTFAVC | 1631 | Q12756 | |
| KTLEMNPCTPNNVEV | 896 | P42702 | |
| PMVCVAISKGTESNQ | 686 | Q9Y4K4 | |
| PCIQLSSKNEASGMV | 36 | Q86XI6 | |
| MDPNQNVKCKIVVVG | 16 | P61587 | |
| SNVMISPEVLCKEGI | 981 | Q92833 | |
| DSNPMVICQLKGGTQ | 206 | Q9Y4I5 | |
| SRAACAVKPQEVQMV | 2121 | P11717 | |
| VLCGDPVMRVSLSQQ | 906 | Q86VV8 | |
| IKNCFTPQTGLSDIM | 266 | A2RUB1 | |
| KGPVLCVVMSSNGEQ | 516 | O43815 | |
| VPLSQECVTKGAMEL | 1876 | O60522 | |
| MIPKGALAVAVAQVC | 221 | P07988 | |
| LSTPEIQKCGDMAVA | 371 | P08582 | |
| IKVTPLQQMLASCTG | 11 | Q8TBP6 | |
| TVGTQVLCPMSDSKI | 416 | B5MCY1 | |
| VMVEPGTTVLQACEK | 41 | P28331 | |
| PGMATKSETQPQVCA | 1011 | Q5VVP1 | |
| LCVPAMNVNDSVTKQ | 271 | O43865 | |
| GMATKSETQPQVCAA | 1016 | Q8IWB4 | |
| PDVKGAVLVCDMSSN | 166 | Q9Y617 | |
| MDVQVGETFKVPSSC | 331 | Q13485 | |
| QPQVEGVDNKMSQCT | 756 | Q9Y6Q9 | |
| PAVQSALQAMKTVCS | 221 | Q8TCU6 | |
| CQGVNTGMAAEVPKV | 116 | Q6UWV7 | |
| CPTVKAAEMAQRLSG | 826 | Q149N8 | |
| VTQPKEEMAQRGCTK | 126 | Q5SSQ6 | |
| TACVLTGQPFDTMKV | 21 | Q9Y619 | |
| MKVQDIPTGADSCVT | 1156 | Q8N122 | |
| TNENMLICAPTGAGK | 491 | Q8N3C0 | |
| SMPFKLAQVVQAACG | 431 | Q7LGC8 | |
| GMATKSETQPQVCAA | 1016 | Q5VYP0 | |
| IFVPTAQDGAQMVCK | 101 | Q9BRP9 | |
| GSIPMQACQQKDVFA | 386 | Q6NZY4 | |
| SNLASVGLCVAKPEM | 61 | P51786 | |
| MNQCLVATGTHEPKN | 241 | Q03405 | |
| GMTVSKPDLIACLEQ | 56 | P0CB33 | |
| VECVASAAMISPGKL | 201 | Q86W11 | |
| QCEVKLLVTASMPGT | 1981 | Q8N2C7 | |
| TMAGAVIAPSTKCKQ | 2761 | Q96T58 | |
| GMATKSETQPQVCAA | 1016 | Q5TZJ5 | |
| LKTQDCLVPMVNSVA | 236 | Q9UBZ9 | |
| GMATKSETQPQVCAA | 1016 | Q5VU36 | |
| IPSQFTRVMGKVCTQ | 471 | Q5PRF9 | |
| TAAQKAQEACGPLEM | 1036 | Q9Y490 | |
| KTMLQNVSAEVCVPV | 796 | Q5SVQ8 | |
| CSVGLMSSVVAPAKE | 6 | Q01959 | |
| AGIAPNTMLAKVCSD | 311 | Q9UBT6 | |
| GCVSQMLIQKQISHP | 191 | Q86UE3 | |
| PQTMTVCQVKLSNGL | 1466 | Q8IZH2 | |
| SETEAVQGNPMKLRC | 31 | Q9NY72 | |
| GVSPRMVTVNDCDAK | 601 | P48066 | |
| DTVPVAAAMCVLKTG | 331 | Q15393 | |
| VSMVTKDNPGVVTCL | 221 | P22314 | |
| QTVKLVCSVTGMALP | 246 | Q06330 | |
| MGTVAKQLVPSCVTV | 61 | P49765 | |
| EQEKSLPGVVMALVC | 1066 | Q9UPU5 | |
| KPSVFVMKNGTNVAC | 6 | B7Z8K6 | |
| GSMVNTCQNPEIFKE | 301 | Q3SY77 | |
| EMTNKASKEPVGCVN | 551 | Q86XD8 | |
| LITTLQTQPGAVRCM | 2141 | P01266 | |
| QQAIALAKEVSCPMS | 2431 | P01266 | |
| QGQPVKLNCSVEGME | 56 | Q06418 | |
| VVPCGTEKNFTNGMV | 1046 | Q8NFA0 | |
| KAAEGCVMSSQPQNE | 216 | Q03167 | |
| SAMQQGPKEFIECVS | 2396 | Q9P2D8 | |
| LCTAKSPQQVMGSLV | 191 | Q9UHQ1 | |
| EMLCKGLSQPTSNLV | 156 | Q9HD90 | |
| MKRVTGCILSNVNTP | 106 | Q9BZQ4 |